JP2018531287A5 - - Google Patents

Download PDF

Info

Publication number
JP2018531287A5
JP2018531287A5 JP2018537732A JP2018537732A JP2018531287A5 JP 2018531287 A5 JP2018531287 A5 JP 2018531287A5 JP 2018537732 A JP2018537732 A JP 2018537732A JP 2018537732 A JP2018537732 A JP 2018537732A JP 2018531287 A5 JP2018531287 A5 JP 2018531287A5
Authority
JP
Japan
Prior art keywords
compound
nhco
formula
conh
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018537732A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018531287A (ja
JP2018531287A6 (ja
JP7065775B2 (ja
Filing date
Publication date
Priority claimed from GBGB1517859.3A external-priority patent/GB201517859D0/en
Application filed filed Critical
Publication of JP2018531287A publication Critical patent/JP2018531287A/ja
Publication of JP2018531287A6 publication Critical patent/JP2018531287A6/ja
Publication of JP2018531287A5 publication Critical patent/JP2018531287A5/ja
Application granted granted Critical
Publication of JP7065775B2 publication Critical patent/JP7065775B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018537732A 2015-10-08 2016-10-07 化合物及びそれらの治療用途 Active JP7065775B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1517859.3 2015-10-08
GBGB1517859.3A GB201517859D0 (en) 2015-10-08 2015-10-08 Novel compounds and therapeutic uses thereof
PCT/GB2016/053134 WO2017060729A1 (en) 2015-10-08 2016-10-07 Compounds and therapeutic uses thereof

Publications (4)

Publication Number Publication Date
JP2018531287A JP2018531287A (ja) 2018-10-25
JP2018531287A6 JP2018531287A6 (ja) 2018-12-13
JP2018531287A5 true JP2018531287A5 (https=) 2019-11-21
JP7065775B2 JP7065775B2 (ja) 2022-05-12

Family

ID=55130801

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018537732A Active JP7065775B2 (ja) 2015-10-08 2016-10-07 化合物及びそれらの治療用途

Country Status (9)

Country Link
US (2) US10953100B2 (https=)
EP (1) EP3359201A1 (https=)
JP (1) JP7065775B2 (https=)
CN (1) CN108472381B (https=)
AU (1) AU2016335365B2 (https=)
GB (1) GB201517859D0 (https=)
IL (1) IL258511B (https=)
WO (2) WO2017060729A1 (https=)
ZA (1) ZA201802256B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201707076D0 (en) * 2017-05-04 2017-06-21 Centauri Therapeutics Ltd Novel compounds and therapeutic uses thereof
WO2018051085A1 (en) 2016-09-13 2018-03-22 Centauri Therapeutics Limited Novel compounds and therapeutic uses thereof
GB201705684D0 (en) * 2017-04-07 2017-05-24 Centauri Therapeutics Ltd Novel compounds and therapeutic uses thereof
GB201705686D0 (en) * 2017-04-07 2017-05-24 Centauri Therapeutics Ltd Novel compounds and therapeutic uses thereof
GB201707079D0 (en) * 2017-05-04 2017-06-21 Centauri Therapeutics Ltd Novel compounds and therapeutics uses thereof
GB201816554D0 (en) * 2018-10-10 2018-11-28 Centauri Therapeutics Ltd Novel compounds and therapeutic uses thereof
CN111748089B (zh) * 2019-03-28 2023-07-18 成都先导药物开发股份有限公司 一种生物素标记化合物以及确定化合物结合靶标蛋白的方法
CN116535449B (zh) * 2023-03-22 2025-09-16 华东理工大学 一种糖基没食子酸类衍生物及其制备方法与在制备乳腺癌靶向诊疗材料中的应用
GB202406865D0 (en) 2024-05-15 2024-06-26 Centauri Therapeutics Ltd Novel compounds and therapeutics uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6172045B1 (en) 1994-12-07 2001-01-09 Neorx Corporation Cluster clearing agents
US7645743B2 (en) * 1999-12-22 2010-01-12 Altermune, Llc Chemically programmable immunity
JP2005535723A (ja) * 2002-08-20 2005-11-24 バイオティ セラピィーズ コープ 腫瘍特異的オリゴ糖エピトープおよびその用途
JP4430344B2 (ja) * 2002-09-09 2010-03-10 独立行政法人科学技術振興機構 多岐用途型リンカー化合物及びリガンド、並びにそれらの製造方法
EP1653977A2 (en) * 2003-07-17 2006-05-10 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Treatment of disorders associated with natural killer t cells
CN101360728A (zh) * 2005-10-25 2009-02-04 艾吉拉医疗股份有限公司 Iap bir结构域结合化合物
US7998486B2 (en) 2006-10-25 2011-08-16 Newlink Genetics Corporation Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes
BRPI1011269A2 (pt) * 2009-05-05 2016-09-27 Altermune Technologies Llc imunidade quimicamente programável
US9636419B2 (en) * 2013-10-11 2017-05-02 The Universit of Kansas Targeting multiple receptors on a cell surface for specific cell targeting
GB201411150D0 (en) * 2014-06-23 2014-08-06 Altermune Technologies Llc Novel aptamers and therapeutic uses thereof

Similar Documents

Publication Publication Date Title
JP2018531287A5 (https=)
TWI362934B (en) Phosphonate analogs of hiv inhibitor compounds
CN104530417B (zh) 一种多官能化h型聚乙二醇衍生物及其制备方法
JP2006507265A5 (https=)
JP2006512300A5 (https=)
JP6472784B2 (ja) 細胞内在化を誘導するためのｃｄ２０結合免疫毒素及びそれを用いる方法
DE60125797T2 (de) Impfstoffzusammesetzung
JP2011521662A5 (https=)
FI3796912T3 (fi) Antiproliferatiivisia yhdisteitä ja bcma:n ja cd3:n vastainen bispesifinen vasta-aine yhdistelmäkäyttöön
JP2021532154A (ja) 抗ｈｉｖ化合物
JP2018532721A (ja) 治療剤の細胞内送達のための化合物および組成物
CN104530415A (zh) 一种异官能化y型聚乙二醇衍生物、制备方法及其生物相关物质
JP2012526130A (ja) 化学的にプログラム可能な免疫
JP2018519302A5 (https=)
WO2003066069A1 (en) Polymers for delivering peptides and small molecules in vivo
CN102307896A (zh) 基于ⅲ型纤连蛋白结构域的支架组合物、方法及用途
JP2018502131A5 (https=)
JP2013532971A5 (https=)
JP2012501959A5 (https=)
JP2019526614A5 (https=)
JP7185622B2 (ja) 新規化合物及びその治療上の使用
RU2011123700A (ru) Нонапептид с противоопухолевой активностью
JP2013504603A5 (https=)
RU2018101662A (ru) Иммуноглобулин с одним вариабельным доменом против f-белка pcb
WO2005061534A3 (en) Improved tuberculosis vaccines